Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease

Blood. 2009 Apr 16;113(16):3885-6. doi: 10.1182/blood-2009-01-196329.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anemia, Hemolytic, Autoimmune / blood
  • Anemia, Hemolytic, Autoimmune / drug therapy*
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Complement Inactivating Agents / administration & dosage*
  • Complement System Proteins*
  • Humans
  • Immunoglobulin M / blood
  • Male
  • Remission Induction
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Complement Inactivating Agents
  • Immunoglobulin M
  • Complement System Proteins
  • eculizumab